Pages that link to "Q77719323"
Jump to navigation
Jump to search
The following pages link to Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group (Q77719323):
Displaying 50 items.
- IFITM3 inhibits influenza A virus infection by preventing cytosolic entry (Q21090493) (← links)
- The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews (Q21090775) (← links)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis (Q24644585) (← links)
- Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza (Q24672633) (← links)
- The Role of Neuraminidase Inhibitors in the Treatment and Prevention of Influenza (Q24793414) (← links)
- Impact of patient characteristics on the risk of influenza/ILI-related complications (Q24805282) (← links)
- Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness (Q27000668) (← links)
- Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract (Q28343667) (← links)
- In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201 (Q28349519) (← links)
- Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial (Q28359768) (← links)
- Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial (Q28475986) (← links)
- Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic (Q30204152) (← links)
- Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands (Q30229855) (← links)
- Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis (Q30233416) (← links)
- Recent progress in anti-influenza chemotherapy. (Q30326042) (← links)
- The treatment of influenza with antiviral drugs (Q30332377) (← links)
- H5N1 influenza pandemic: contingency plans. (Q30351234) (← links)
- WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. (Q30358901) (← links)
- Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the De (Q30359034) (← links)
- Pandemic flu. Clinical management of patients with an influenza-like illness during an influenza pandemic. (Q30360609) (← links)
- Antivirals for influenza: strategies for use in pediatrics (Q30393095) (← links)
- Outcome of pandemic H1N1 pneumonia: clinical and radiological findings for severity assessment. (Q30404367) (← links)
- ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION. (Q30404586) (← links)
- Influenza: clinical symptoms, diagnostics and therapy (Q30405546) (← links)
- Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States (Q30406680) (← links)
- Recent advances in the diagnosis and treatment of influenza pneumonia. (Q30415002) (← links)
- In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication (Q30453074) (← links)
- Antiviral agents for influenza: a comparison of cost-effectiveness data (Q33226840) (← links)
- Do pediatricians manage influenza differently than internists? (Q33330757) (← links)
- The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae (Q33554796) (← links)
- Comparison of a new gold immunochromatographic assay for the rapid diagnosis of the novel influenza A (H7N9) virus with cell culture and a real-time reverse-transcription PCR assay (Q33562461) (← links)
- A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting (Q33581365) (← links)
- How to treat influenza and colds (Q33727502) (← links)
- Zanamivir: a review of clinical safety (Q33748023) (← links)
- Zanamivir: a review of its use in influenza (Q33768776) (← links)
- Respiratory viral infections in the elderly (Q33834945) (← links)
- Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. (Q33970922) (← links)
- Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR (Q33971331) (← links)
- Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies (Q33978456) (← links)
- Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation (Q33980106) (← links)
- Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial (Q34099223) (← links)
- The common cold (Q34169126) (← links)
- Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. (Q34171619) (← links)
- Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice (Q34220587) (← links)
- The common cold: a review of the literature (Q34323845) (← links)
- Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications (Q34481313) (← links)
- Zanamivir: an update of its use in influenza (Q34492611) (← links)
- Efficacy and safety of clearing heat and detoxifying injection in the treatment of influenza: a randomized, double-blinded, placebo-controlled trial (Q34660518) (← links)
- Management of influenza symptoms in healthy adults (Q34742405) (← links)
- Antivirals for influenza: what is their role in the older patient? (Q34975814) (← links)